Twitter

Archive for February 27th, 2012


Fibroid Ablation Study – Large Fibroids

Conditions :   Leiomyoma;   Uterine Fibroids;   Menorrhagia Intervention :   Device: VizAblate System Sponsor :   Gynesonics Not yet recruiting – verified February 2012

Read More...

Antimicrobial Catheter Lock Solution for the Treatment of Central Line Associated Bloodstream Infection (CLABSI)

Condition :   Infection Intervention :   Other: Antimicrobial Solution Sponsors :   M.D. Anderson Cancer Center;   Triax Not yet recruiting – verified February 2012

Read More...

Rituximab and Combination Chemotherapy in Treating Patients With Previously Untreated High- or High-Intermediate-Risk Diffuse Large B-Cell Lymphoma

Conditions :   Contiguous Stage II Adult Diffuse Large Cell Lymphoma;   Noncontiguous Stage II Adult Diffuse Large Cell Lymphoma;   Stage I Adult Diffuse Large Cell Lymphoma;   Stage III Adult Diffuse Large Cell Lymphoma;   Stage IV Adult Diffuse Large Cell Lymphoma Interventions :   Biological: rituximab;   Drug: cyclophosphamide;   Drug: doxorubicin hydrochloride;   Drug: vincristine sulfate;   Drug: prednisone;   Other: laboratory biomarker analysis;   Other: pharmacological study Sponsors :   Fox Chase Cancer Center;   Genentech Not yet recruiting – verified February 2012

Read More...

A Five-Year Quality of Life Study for Cancer Patients

Condition :   Cancer Intervention :   Sponsors :   Constantine A. Kotsanis;   The Best Answer for Cancer Foundation Recruiting – verified February 2012

Read More...

Sorafenib Plus Tegafur-uracil (UFT) Versus Sorafenib as First Line Systemic Treatment for Patients With Advanced Stage HCC, Unresectable & Not Eligible for Local Ablation and/or TACE

Condition :   Advanced Hepatocellular Carcinoma Interventions :   Drug: Sorafenib;   Drug: sorafenib plus tegafur-uracil Sponsor :   Egyptian Society of Liver Cancer Active, not recruiting – verified February 2012

Read More...

Early Recognition and Optimal Treatment of Delirium in Patients With Advanced Cancer

Conditions :   Delirium;   Advanced Cancer Interventions :   Drug: Olanzapine;   Drug: Haloperidol Sponsors :   VU University Medical Center;   ZonMw: The Netherlands Organisation for Health Research and Development Recruiting – verified February 2012

Read More...

Promising new technique to rescue the immune system

Researchers report on a promising new technique that potentially could turn immune system killer T cells into more effective weapons against infections and possibly cancer.

Read More...

RNA interference cancer treatment? Delivering RNA with tiny sponge-like spheres

For the past decade, scientists have been pursuing cancer treatments based on RNA interference — a phenomenon that offers a way to shut off malfunctioning genes with short snippets of RNA. However, one huge challenge remains: finding a way to efficiently deliver the RNA. Scientists have now come up with a novel delivery vehicle in which RNA is packed into microspheres so dense that they withstand degradation until they reach their destinations. The new system knocks down expression of specific genes as effectively as existing delivery methods, but with a much smaller dose of particles.

Read More...

Cupcakes for Cancer sells sweets to fight disease

Hundreds attend the Cupcake Camp Conejo Valley, a fundraiser to benefit the Wellness Community Valley/Ventura. The fundraiser was presented by Cupcakes for Cancer in Westlake Village on Sunday.

Read More...

Gloria Gemma Breast Cancer Foundation donation will cover mammograms for women aged 40-49

The Gloria Gemma Breast Cancer Research Foundation has donated $40,000 to the state Department of Health to help cover the cost of mammograms for eligible women between the ages of 40 and 49.

Read More...